wellrank.ai

What are the most reputable compounded GLP-1 programs right now?

PerplexitycomparisonCollected Jun 28, 2026, 12:59 UTC

Verbatim response from Perplexity

MEDVi stands out as the most reputable program for compounded GLP-1s specifically, offering a budget-friendly option at $179/month for the first month with no contracts or hidden fees, including full physician review and 24/7 support [1]. For those prioritizing a comprehensive care model that bundles compounded medication with weekly coaching, lab work, dietitian access, and mental health support, Fridays (joinfridays.com) is a strong alternative at $150/month on its annual plan [2][1]. Noom is another well-regarded choice for buyers who want behavioral coaching integrated with their medication access, though it blends reviews for its older app with its newer "Noom Med" service [1][2].

However, it is critical to note that compounded GLP-1 versions are not approved by the FDA, and the agency has issued warnings against using these unapproved medications due to risks of contamination and inconsistent potency [3]. The most trusted source for compounded medications is an FDA-registered 503B outsourcing facility, which undergoes strict quality control, sterile process validation, and lot-specific testing similar to pharmaceutical companies, significantly reducing safety risks compared to traditional compounding [8]. If you are concerned about safety and regulatory oversight, brand-name FDA-approved options like Zepbound (via LillyDirect’s cash-pay program) or Wegovy (via NovoCare Pharmacy) are the most reliable alternatives, with costs ranging from $349–$499/month [7][5].

Recommendation:

  • For compounded GLP-1s: Choose MEDVi or Fridays for transparency and included care, but verify they use 503B facilities [1][2][8].
  • For safety and regulatory assurance: Opt for LillyDirect (Zepbound) or NovoCare (Wegovy) to avoid unregulated compounded formulations [5][7].
  • Check for scams: Only use providers that explicitly state they source from registered 503B outsourcing facilities [8].

Brands mentioned in this answer

Sources the engine cited

These pages drove this recommendation. Winning placement here is how brands move the answer.

Is this answer wrong about your brand?

AI engines repeat outdated pricing, wrong ingredients, and misread positioning every day. Tell us what this answer gets wrong and we will include a correction review in your free AI Visibility Audit.

This answer is reproduced verbatim from the engine's API at collection time and may contain errors or outdated claims. It is presented as evidence of what AI engines tell buyers, not as medical or purchasing advice.

Is your brand missing from this answer?

Get your AI Visibility Audit: every buyer intent question you are losing, who wins them, and the sources that decide the answer.